triptolide has been researched along with Choroid Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Huang, C; Jin, C; Lai, K; Li, L; Li, Y; Xu, F; Zhong, X | 1 |
1 other study(ies) available for triptolide and Choroid Neovascularization
| Article | Year |
|---|---|
Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization.
Topics: Animals; Cell Movement; Choroidal Neovascularization; Delayed-Action Preparations; Diterpenes; Drug Liberation; Endothelial Cells; Epoxy Compounds; Liposomes; Macrophages; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Oligopeptides; Phenanthrenes; Retina; Vascular Endothelial Growth Factor A | 2020 |